Men who attended a Bavarian General Medicine Practice were
confidentially invented here. Two male study groups were enrolled to characterize
adiposity or hypertriglyceridemia showing that these men were at baseline risk
for hypertension . Adverse alcohol consumption mediated dysfunction of
renal endothelium as shown here and before . This study found that alcohol
use aggravated dyslipidemia, fatty liver disease and critical fasting blood
glucose of obese men predicting then late hepatorenal disorders. Overall, two
male study groups showed a relevant proportion of men who reported alcohol consumption showing then critical morning urines indicating dysfunction of renal
endothelium. The present report looked also at healthy men who reported
positive lifestyle behaviour and at men with
nonalcohol adiposity and nonalcohol hypertriglyceridemia who then
showed normal morning urines indicating functional renal endothelium.
Relatively young men at risk were motivated to replace adverse alcohol use by
healthy liquids without alcohol and by higher quality of food.
Korth, R.M. (2006) Gender obesity, alcohol use, hyper- lipide-mia, hypertension and decline of renal endothelial barriers, Journal of Men’s Health and Gender, 3, 279-289.
Korth, R., Zimmermann, K. and Richter, W. (1994) “Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte-macrophage-like U937 cells. Chemistry Physic of Lipids, 70, 109-119.
Barzilay, J.J., Peterson, D., Cushman, M., Heckbert, S.R., Cao, J.J., Blaum, C., Tracy, R.P., Klein, R. and Herrington, D.M. (2004) The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension. The Car-diovascular Health Study, American Kidney Disease, 44, 25-34.
Berenson, G.S., Srinivasan, S.R., Bao, W., Newmann, W.P., Tracy, R.E. and Wattigney, W.A. (1998) Associa- tion between multiple cardiovascular risk factors and atherosclerosis in children and young adults, New England Journal of Medicine, 338, 1650-1656.
Coustan, D.R., Lowe, L.P., Metzger, B.E. and Dyer, A.R. (2007) The hyperglycemia and adverse pregnany outcome (paving the way for new diagnostic criteria for gestational diabetes mellitus). American Journal Obstetic and Gyne- cology, 202, 654-657.
Gupta, B.P., Murad, M.H., Clifton, M.M., Prokop, L., Nehra, A. and Ko-pecky, S.L. (2011) “The effect of life- style modification and cardiovascular risk factor reduc- tion on erectil dysfunction: a systemic review and meta-analyis. Archives Internal Medicine, 171, 1797-17803.
Korth, R.M., Hirafuji, M., Beneveniste, J. and Russo-Marie, F. (1995) Human umbilical vein endothelial cells: Specific binding of platelet-activating factor and cytosolic calcium flux. Biochemical Pharmacology, 49, 1793-1799.
Hiramoto, M., Yo-shida, H., Imaizumi, T., Yoshimizu, N. and Satoh, K. (1997) A mutation in plasma platetet activating factor acetylhydrolases (VAL279-Phe) is a genetic risk factor for stroke. Stroke, 28, 2417-2420.
Sacks, F.M., Svetkey, L.P., Vollmer, W.M., Appel, L.J., Bray, G.A., Harsha, D., Obarzanek, E., Conlin, P.R., Miller, E.R., Simons-Morton, D.G., Karanja, N. and Lin, P.H.L.N. (2001) “DASH-Sodium Collaboration Re-search Group. Effects on blood pressure of reduced dietary so- dium and the dietary approaches to stop hypertension (DASH) diet. New England Journal Medicine, 344, 3-10.